Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis
<p><strong>Background</strong> Levofloxacin is used for the treatment of multidrug-resistant tuberculosis; however the optimal dose is unknown.</p> <p><strong>Methods</strong> We used the hollow fiber system model of tuberculosis (HFS-TB) to identify 0–24 h...
Автори: | Deshpande, D, Pasipanodya, JG, Mpagama, SG, Bendet, P, Srivastava, S, Koeuth, T, Lee, PS, Bhavnani, SM, Ambrose, PG, Thwaites, G, Heysell, SK, Gumbo, T |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Oxford University Press
2018
|
Предмети: |
Схожі ресурси
Схожі ресурси
-
Wild-Type MIC Distribution for Re-evaluating the Critical Concentration of Anti-TB Drugs and Pharmacodynamics Among Tuberculosis Patients From South India
за авторством: Azger Dusthackeer, та інші
Опубліковано: (2020-06-01) -
Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B from South Korea
за авторством: Trang Nguyen Doan Dang, та інші
Опубліковано: (2014-10-01) -
Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin
за авторством: Arti Shrivas, та інші
Опубліковано: (2025-03-01) -
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors
за авторством: Manoj Chandran, та інші
Опубліковано: (2015-01-01) -
Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China
за авторством: Chenqian Wang, та інші
Опубліковано: (2022-11-01)